Covivio (COV) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
3 Feb, 2026Executive summary
H1 2024 marked by strategic transformation, with reinforced balance sheet, portfolio rebalancing, and increased hotel exposure to 20% of the portfolio.
Major deals included a Berlin residential JV (€274m) and a hotel asset swap with AccorInvest, alongside an increased stake in Covivio Hotels.
Recurring net result grew 3.3% year-over-year to €231m, with guidance raised to €460m for 2024.
Financial structure strengthened via €311m in new disposals, scrip dividend, and improved liquidity, with S&P confirming BBB+ rating.
Financial highlights
Recurring earnings for H1 2024 reached €231m (+3.3% YoY); adjusted EPS at €2.24, down due to higher share count from scrip dividend.
Like-for-like revenue growth of 6.5%, with total revenues up 1.8% at current scope.
Net rental income up 1% to €284.9m; EBITDA from hotel operations up 9% to €23.9m.
Portfolio valued at €15.4bn, diversified across Germany (42%), France (34%), and hotels (20%).
Occupancy rate increased to 97.1% (+1.3pt YoY); average firm lease term at 6.8 years.
Outlook and guidance
2024 recurring net result guidance raised to €460m (€4.30 per share), up from €440m.
Strategic focus on further hotel sector reinforcement, extracting growth from existing assets, and value creation in Paris, Milan, and Berlin.
High single-digit like-for-like rental growth expected for offices in 2024.
Full cash dividend targeted for 2024, with payout ratio above 80%.
Latest events from Covivio
- Recurring net result per share up 6.4%, NAV per share up 3.9%, and 2026 targets 4% further growth.COV
H2 202520 Feb 2026 - Revenue up 4.8% with 2025 guidance confirmed; strong operations and ESG leadership.COV
Q3 202520 Feb 2026 - Recurring net result up 14% and 2025 guidance raised on strong H1 and market recovery.COV
H1 202527 Jan 2026 - Q1 2025 revenue up 5.4%, with high occupancy and guidance and dividend increase confirmed.COV
Q1 202527 Jan 2026 - Revenue up 6.8% like-for-like, occupancy at 97.3%, and €391m in disposals signed.COV
Q3 202419 Jan 2026 - Balanced growth, centrality, and ESG leadership drive portfolio transformation to 2030.COV
CMD 202412 Jan 2026 - Recurring net income up 10% and dividend up 6%, with 2025 guidance for further growth.COV
Q4 202417 Dec 2025